1. Home
  2. TOMZ vs IMNN Comparison

TOMZ vs IMNN Comparison

Compare TOMZ & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.70

Market Cap

15.2M

Sector

Finance

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.30

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
IMNN
Founded
1979
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
12.5M
IPO Year
N/A
1985

Fundamental Metrics

Financial Performance
Metric
TOMZ
IMNN
Price
$0.70
$3.30
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.50
$182.61
AVG Volume (30 Days)
16.0K
48.8K
Earning Date
11-14-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,688,341.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$68.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$2.99
52 Week High
$1.20
$41.22

Technical Indicators

Market Signals
Indicator
TOMZ
IMNN
Relative Strength Index (RSI) 48.53 38.67
Support Level $0.70 $3.39
Resistance Level $0.79 $3.89
Average True Range (ATR) 0.03 0.24
MACD -0.00 -0.01
Stochastic Oscillator 54.04 2.82

Price Performance

Historical Comparison
TOMZ
IMNN

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: